ReviewJournal of clinical medicine2025
Secondary Prevention After Acute Coronary Syndromes in Women: Tailored Management and Cardiac Rehabilitation.
Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Obesity and Beyond: Lifestyle Patterns and Cardiometabolic Burden in High-Risk Patients with Coronary Artery Disease-Moving Toward Personalized Prevention.Diseases (Basel, Switzerland) · 2026Article
- Impact of atypical presenting symptoms on door-to-balloon time and mortality outcomes in ST-segment elevation myocardial infarction.BMC emergency medicine · 2025Article
- Plaque, Prodromes, and Personalized Care: A Case Report Reframing Left Main Coronary Artery Occlusion in Females.Cureus · 2025Article
- Reperfusion injury in STEMI: a double-edged sword.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondary prevention after acute coronary syndromes is the key strategy to reduce the residual cardiovascular disease risk. A tailored assessment is necessary to suggest the best management and treatment for patients. Sex and gender differences should be strongly considered during cardiovascular evaluation and risk estimation. Indeed, women have a worse outcome than men and are less likely to receive appropriate treatment and evidence-based management. Proper lifestyle management, guideline-directed medical therapy, risk factor management, and cardiac rehabilitation should be recommended early after an acute event in women to reduce the high risk of recurrent events and mortality and improve quality of life. Women-focused cardiac rehabilitation and secondary prevention represent a necessary step in the management and treatment of patients to ensure the best evidence-based care after acute coronary syndromes. This review offers a critical, updated, and comprehensive overview of the appropriate strategies for secondary prevention in women after acute coronary syndromes and long-term treatment, with a focus on cardiac rehabilitation programs. Furthermore, gaps in evidence on this topic and practical recommendations will be provided.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.